论文信息 - Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment - 字舞流文

Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment

O. Garrone | L. Gammaitoni | L. Licitra | D. Sangiolo | N. Denaro | E. Fiorino | D. Galizia | Silvia Minei | M. Paccagnella | A. Abbona | P. Bossi | M. Merlano